Page 53 - Read Online
P. 53

Licordari et al. Vessel Plus 2022;6:12                                     Vessel Plus
               DOI: 10.20517/2574-1209.2021.86



               Original Article                                                              Open Access



               Mid-basal left ventricular longitudinal dysfunction as

               a prognostic marker in mutated transthyretin-related
               cardiac amyloidosis


                                                                            2
                                                                                           1
                                                              3
                                            2
                              1
               Roberto Licordari , Fabio Minutoli , Francesco Cappelli , Antonio Micari , Luigi Colarusso , Federico
                                                         1
                                                                            1
                                       1
                                                                                         4
               Antonio Francesco Di Paola , Mariapaola Campisi , Antonino Recupero , Anna Mazzeo , Gianluca Di Bella 1
               1
                Rare Cardiac Disease Centre, Department of Clinical and Experimental Medicine, University of Messina, Messina 98125, Italy.
               2
                Department of Biomedical Sciences and Morphologic and Functional Images, University of Messina, Messina 98125, Italy.
               3
                Tuscan regional amyloid center, Careggi University Hospital, Firenze 50134, Italy.
               4
                Neurology Unit, Department of Clinical and Experimental Medicine, University of Messina, Messina 98125, Italy.
               Correspondence to: Dr. Roberto Licordari, Rare Cardiac Disease Centre, Department of Clinical and Experimental Medicine, Via
               Consolare Valeria 1, University of Messina, Messina 98125, Italy. E-mail: robertolicordari@gmail.com
               How to cite this article: Licordari R, Minutoli F, Cappelli F, Micari A, Colarusso L, Di Paola FAF, Campisi M, Recupero A, Mazzeo
               A, Di Bella G. Mid-basal left ventricular longitudinal dysfunction as a prognostic marker in mutated transthyretin-related cardiac
               amyloidosis. Vessel Plus 2022;6:12. https://dx.doi.org/10.20517/2574-1209.2021.86
               Received: 11 Jun 2021  First Decision: 17 Aug 2021  Revised: 26 Aug 2021  Accepted: 12 Oct 2021   Published: 17 Feb 2022
               Academic Editors: Alexander D. Verin, Ugolino Livi, Gianfranco Sinagra  Copy Editor: Yue-Yue Zhang  Production Editor: Yue-
               Yue Zhang
               Abstract
               Aim: Mutated transthyretin (TTRv) cardiac amyloidosis (CA) represents an uncommon form of CA. Our study
               aimed to assess the best echocardiographic prognostic parameter in the early stage of TTRv amyloidosis with
               cardiomyopathy.

               Methods: In total, 99 patients with TTRv in New York Heart Association class I or II and with no clinical history of
               previous cardiac disease were studied. Assessment with  99m Tc-DPD whole-body scan showed CA in 46 patients. At
               the first medical contact, an echocardiographic examination was performed. In addition to conventional left
               ventricular (LV), echocardiographic measurements [ejection fraction (EF), dimensions and diastolic function,
               global longitudinal strain (GLS), longitudinal strain of the 4 apical segments, longitudinal strain of the 12 mid-basal
               segments (MBLS)] and their ratio [relative regional strain ratio (RRSR)] were obtained. Patient outcome was
               evaluated during a follow-up with an average duration of six years. Cardiac death and appropriate implantable
               cardiac defibrillator (ICD) shock were considered major events.








                           © The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing,
                           adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as
               long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and
               indicate if changes were made.

                                                                                             www.vpjournal.net
   48   49   50   51   52   53   54   55   56   57   58